Cargando…

Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics

Stem cell therapy mainly uses natural stem cells for transplantation, and the use of genetic engineering to optimize stem cell products is a very important process. This article reviews successful gene modification methods in the field of immune cell therapy and summarizes some attempts at stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Siyu, Tang, Hao, Li, Cheng, Ma, Jiajia, Ali, Maqsood, Dong, Qi, Wu, Jiajia, Hui, Yang, Sun, Chongran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514184/
https://www.ncbi.nlm.nih.gov/pubmed/36166137
http://dx.doi.org/10.1007/s12015-022-10454-5
_version_ 1784798222900789248
author Li, Siyu
Tang, Hao
Li, Cheng
Ma, Jiajia
Ali, Maqsood
Dong, Qi
Wu, Jiajia
Hui, Yang
Sun, Chongran
author_facet Li, Siyu
Tang, Hao
Li, Cheng
Ma, Jiajia
Ali, Maqsood
Dong, Qi
Wu, Jiajia
Hui, Yang
Sun, Chongran
author_sort Li, Siyu
collection PubMed
description Stem cell therapy mainly uses natural stem cells for transplantation, and the use of genetic engineering to optimize stem cell products is a very important process. This article reviews successful gene modification methods in the field of immune cell therapy and summarizes some attempts at stem cell gene editing in current research. Cell bridging is an innovative cutting-edge strategy that includes the specific recognition and signal transduction of artificial receptors. The “off-the-shelf” cell strategies mainly introduce the advantages of allogeneic cell therapy and how to overcome issues such as immunogenicity. Gene regulatory systems allow us to manipulate cells with small molecules to control cellular phenotypes. In addition, we also summarize some important genes that can provide a reference for cell genetic engineering. In conclusion, we summarize a variety of technical strategies for gene editing cells to provide useful ideas and experiences for future stem cell therapy research. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9514184
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-95141842022-09-28 Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics Li, Siyu Tang, Hao Li, Cheng Ma, Jiajia Ali, Maqsood Dong, Qi Wu, Jiajia Hui, Yang Sun, Chongran Stem Cell Rev Rep Article Stem cell therapy mainly uses natural stem cells for transplantation, and the use of genetic engineering to optimize stem cell products is a very important process. This article reviews successful gene modification methods in the field of immune cell therapy and summarizes some attempts at stem cell gene editing in current research. Cell bridging is an innovative cutting-edge strategy that includes the specific recognition and signal transduction of artificial receptors. The “off-the-shelf” cell strategies mainly introduce the advantages of allogeneic cell therapy and how to overcome issues such as immunogenicity. Gene regulatory systems allow us to manipulate cells with small molecules to control cellular phenotypes. In addition, we also summarize some important genes that can provide a reference for cell genetic engineering. In conclusion, we summarize a variety of technical strategies for gene editing cells to provide useful ideas and experiences for future stem cell therapy research. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2022-09-27 2023 /pmc/articles/PMC9514184/ /pubmed/36166137 http://dx.doi.org/10.1007/s12015-022-10454-5 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Li, Siyu
Tang, Hao
Li, Cheng
Ma, Jiajia
Ali, Maqsood
Dong, Qi
Wu, Jiajia
Hui, Yang
Sun, Chongran
Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics
title Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics
title_full Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics
title_fullStr Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics
title_full_unstemmed Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics
title_short Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics
title_sort synthetic biology technologies and genetically engineering strategies for enhanced cell therapeutics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514184/
https://www.ncbi.nlm.nih.gov/pubmed/36166137
http://dx.doi.org/10.1007/s12015-022-10454-5
work_keys_str_mv AT lisiyu syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT tanghao syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT licheng syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT majiajia syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT alimaqsood syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT dongqi syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT wujiajia syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT huiyang syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics
AT sunchongran syntheticbiologytechnologiesandgeneticallyengineeringstrategiesforenhancedcelltherapeutics